Advertisement
Surgical Research Reviews| Volume 129, ISSUE 6, P664-667, June 2001

Download started.

Ok

Clinical applications of ischemic preconditioning: From head to toe

      Abstract

      Surgery 2001;129:664-7.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Murry CE
        • Jennings RB
        • Reimer KA
        Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.
        Circulation. 1986; 74: 1124-1136
        • Cleveland Jr, JC
        • Wollmering MM
        • Meldrum DR
        • Rowland RT
        • Rehring TF
        • Sheridan BC
        • et al.
        Ischemic preconditioning in human and rat ventricle.
        Am J Physiol. 1996; 271: H1786-H1794
        • Pomerantz BJ
        • Koo J
        • Shames BD
        • Cleveland Jr, JC
        • Banerjee A
        • Harken A.
        Adenosine preconditioning reduces both pre and post ischemic arrhythmias in human myocardium.
        J Surg Res. 2000; 90: 191-196
        • Shiki K
        • Hearse D.
        Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias.
        Am J Physiol. 1987; 253: H1470-H1476
        • Liu GS
        • Thornton J
        • VanWinkle DM
        • Stanley AWH
        • Olsson RA
        • Downey JM
        Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart.
        Circulation. 1991; 84: 350-356
        • Banerjee A
        • Locke-Winter C
        • Rogers KB
        • Mitchell MB
        • Brew EC
        • Cairns CB
        • et al.
        Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha1-adrenergic mechanism.
        Circ Res. 1993; 73: 656-670
        • Brew EC
        • Mitchell MB
        • Rehring TF
        • Gamboni-Robertson F
        • Mclntyre Jr, RC
        • Harken AH
        • et al.
        The role of bradykinin in cardiac functional protection after global ischemia-reperfusion in the rat heart.
        Am J Physiol. 1995; 269: H1370-H1378
        • Schultz JE
        • Hsu AK
        • Gross GJ
        Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in rat heart.
        Circ Res. 1996; 78: 1100-1104
        • Mitchell MB
        • Meng X
        • Parker CG
        • Brown JM
        • Harken AH
        • Banerjee A.
        Preconditioning of isolated rat heart is mediated by protein kinase C.
        Circ Res. 1995; 76: 73-81
        • Baines CP
        • Wang L
        • Cohen MV
        • Downey JM
        Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart.
        J Mol Cell Cardiol. 1998; 30: 383-392
        • Maulik N
        • Watanabe M
        • Zu YL
        • Huang Ck
        • Cordis GA
        • Schley JA
        • et al.
        Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts.
        FEBS Lett. 1996; 396: 233-237
        • Gross GJ
        • Auchampach JA
        Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs.
        Circ Res. 1992; 70: 223-233
        • Cleveland Jr, JC
        • Meldrum DR
        • Cain BS
        • Banerjee A
        • Harken AH
        Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium.
        Circulation. 1997; 96: 29-32
        • Kloner RA
        • Shook T
        • Przyklenk K
        • Davis VG
        • Junio L
        • Matthews RV
        • et al.
        Previous angina alters in hospital outcome in TIMI 4. A clinical correlate to preconditioning?.
        Circulation. 1995; 91: 37-47
        • Andreotti F
        • Pasceri V
        • Hackett DR
        • Davies GJ
        • Haider AW
        • Maseri A.
        Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction.
        N Engl J Med. 1996; 334: 7-12
        • Deutsch E
        • Berger M
        • Kussmaul WG
        • Hirshfeld JW
        • Hermann HC
        • Laskey WK
        Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features.
        Circulation. 1990; 82: 2044-2051
        • Tomai F
        • Crea F
        • Gaspardone A
        • Versaci F
        • De Paulis R
        • Polisca P
        • et al.
        Effects of A1 adenosine receptor blockade by bamiphylline on ischemic preconditioning during coronary angioplasty.
        Eur Heart J. 1996; 17: 846-853
        • Tomai F
        • Crea F
        • Gaspardone A
        • Versaci F
        • Ghini AS
        • De Paulis R
        • et al.
        Phentolamine prevents adaptation to ischemia during coronary angioplasty. Role of alpha-adrenergic receptors in ischemic preconditioning.
        Circulation. 1997; 96: 2171-2177
        • Tomai F
        • Crea F
        • Gaspardone A
        • Versaci F
        • De Paulis R
        • Penta de Peppo A
        • et al.
        Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker.
        Circulation. 1994; 90: 700-705
        • Yellon DM
        • Alkhulaifa A
        • Pugsley WB
        Preconditioning the human myocardium.
        Lancet. 1993; 342: 276-277
        • Mentzer Jr, RM
        • Rahko PS
        • Molina-Viamonte V
        • Canver CC
        • Chopra PS
        • Love RB
        • et al.
        Safety, tolerance, and efficacy of adenosine as an additive to blood cardioplegia in humans during coronary artery bypass surgery.
        Am J Cardiol. 1997; 79: 38-43
        • Lee HT
        • Lafaro RJ
        • Reed GE
        Pretreatment of human myocardium with adenosine during open heart surgery.
        J Cardiac Surg. 1995; 10: 665-676
        • Subramanian V.
        Clinical experience with minimally invasive reoperative coronary bypass surgery.
        Eur J Cardiothorac Surg. 1996; 10: 1058-1062
        • Yadav SS
        • Sindram D
        • Perry DK
        • Clavien PA
        Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway.
        Hepatology. 1999; 30: 1223-1231
        • Totsuka E
        • Fung JJ
        • Urakami A
        • Moras N
        • Ishii T
        • Takahashi K
        • et al.
        Influence of donor cardiopulmonary arrest in human liver transplantation: possible role of ischemic preconditioning.
        Hepatology. 2000; 31: 577-580
        • Kevelaitis E
        • Oubenaissa A
        • Peynet J
        • Mouas C
        • Menasche P.
        Preconditioning by mitochondrial ATP-sensitive potassium channel openers. An effective approach for improving the preservation of heart transplants.
        Circulation. 1999; 100: II345-II350
        • Mounsey RA
        • Pang CV
        • Boyd B
        • Forrest C.
        Augmentation of skeletal muscle survival in the latissimus dorsi porcine model using acute ischemic preconditioning.
        J Otolaryngol. 1992; 21: 315-320
        • Restifo RJ
        • Thomson JG
        The preconditioning TRAM flap: preliminary clinical experience.
        Ann Plast Surg. 1998; 41: 343-347
        • Cheng MH
        • Chen HC
        • Wei FC
        • Su SW
        • Lian SH
        • Brey E.
        Devices for ischemic preconditioning of the pedicled groin flap.
        J Trauma. 2000; 48: 552-557
        • Lee HT
        • Emala CW
        Protective effects of renal ischemic preconditioning and adenosine pretreatment: role of A1 and A3 receptors.
        Am J Physiol. 2000; 278: F380-F387